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Using a Collison nebulizer, aerosols of influenza (A/Udorn/307/72 H3N2) were generated
within a controlled experimental chamber, from known starting virus concentrations. Air
samples collected after variable suspension times were tested quantitatively using both
plaque and polymerase chain reaction assays, to compare the proportion of viable virus
against the amount of detectable viral RNA. These experiments showed that whereas
influenza RNA copies were well preserved, the number of viable viruses decreased by a
factor of 104e105. This suggests that air-sampling studies for assessing infection control
risks that detect only influenza RNA may greatly overestimate the amount of viable virus
available to cause infection.
ª 2015 The Authors. Published by Elsevier Ltd on behalf of the Healthcare Infection
Society. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1Introduction
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but is time-consuming and difficult to perform for airborne
viruses.3
Here, we investigate the impact of aerosolization and air-
sampling on viable and non-viable influenza to inform the
assessment of airborne influenza transmission.Methods
Experimental chamber
Experiments took place inside a stainless steel, controlled
environmental chamber (442.7m, 43.2 m3), designed to
mimic a single-bedded hospital isolation room. This was
maintained at 25C and 30% relative humidity as these condi-
tions have been shown to be optimal for influenza airborne
survival.4 A biosafety class (BSC) II cabinet situated outside the
chamber was connected to the interior by two pipes (polyvinyl
chloride, 850 mm long, 19.9 mm inside diameter, wall thickness
of 1.2 mm) to allow the injection of experimental aerosols and
the extraction of air-samples (Figure 1).Nebulization, air-sampling, virus detection, and
quantification
A laboratory-adapted influenza A/H3N2 strain (A/Udorn/
307/72 H3N2), passaged in eggs, was nebulized using a Collison
jet nebulizer (set at 20 pounds per square inch, to nebulize
8 mL for 30 min), as previously described.5
The starting concentration of virus, pre-nebulization,
was quantified in copies/mL using an in-house quantitative
reverseetranscription real-time polymerase chain reaction
(qRTePCR) assay targeting a 202 nt region of the matrix (M)Figure 1. Experimental chamber and anteroom (A) containing the BSC
(green arrow) and the ‘air-sampling’ inlet to the SKC BioSampler (red
(For interpretation of the references to colour in this figure legend, tgene, using a dilution series of plasmid containing the target
sequence as standards.
Briefly, PCR reactions consisted of 1 SuperScript III Plat-
inum One-Step qRTePCR mastermix (Invitrogen), 0.8 mM each
primer (forward, 50CTTCTAACCGAGGTCGAAACGTA; reverse,
50GGTGACAGGATTGGTCTTGTCTTTA), 0.2 mM probe (50FAM-
TCAGGCCCCCTCAAAGCCGAG-BHQ1), 5 mL purified RNA and
water to make the reaction volume up to 25 mL. Cycling on an
ABI 7500 consisted of 50C for 30min and 95C for 10 min, fol-
lowed by 45 cycles of 95C for 15 s and 60C for 60 s. Live virus
was quantified in plaque-forming units (pfu) per millilitre with
a viral plaque assay using MadineDarby canine kidney (MDCK)
cells kindly provided by the Worldwide Influenza Centre at the
Francis Crick Institute.
The nebulizer source solution contained an initial mean
starting influenza viral load of 3.48107 pfu/mL (or 7.21109
RNA copies/mL) for all experiments. Therefore, assuming that
all 8 mL of this source solution was nebulized into the chamber
and continuously well mixed with the ambient air contained
therein, over the first 0e30min, the volumetric airborne con-
centration of virus was predicted to be 6.44106 pfu/m3 and
1.34109 RNA copies/m3.
For these experiments, there were no mechanical air
changes. A fan positioned on the chamber ceiling ran contin-
uously during these experiments, ensuring that the air in the
chamber, and therefore the airborne virus, was well mixed.Experimental protocol
Experiments to ascertain airborne survival of influenza
entailed switching on the nebulizer for 30min to aerosolize the
virus, then air-sampling from the chamber during the periods:
30e60min (N ¼ 7, where N is the number of experiments
performed), 60e90 min (N ¼ 3) and 90e120 min (N ¼ 3) afterII cabinet. (B) Collison nebulizer source ‘aerosolized virus’ outlet
arrow). (C) Interior of the stainless steel experimental chamber.
he reader is referred to the online version of this article.)
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air is sampled during each 30 min period.
Air-sampling was done using an SKC BioSampler impinger
situated in the BSC II cabinet, through which air was drawn at
20 L/min through 20 mL of a collection fluid that had been
optimized for viral survival (Dulbecco’s Modified Eagle Medium,
supplemented with 0.1% bovine serum albumin, 10 mg/mL
vancomycin, 10 mg/mL gentamycin, and 0.25 mg/mL ampho-
tericin B).
Samples were stored at 4C during each experiment, then
quantified by plaque assay and qRTePCR methods to give pfu/
m3 and RNA copies/m3. Plaque assays were done within 1 h of
experiment completion; preliminary experiments showed the
virus in solution to be stable at 4C for up to 4 h (practical
details available upon request).
Results
Sampling directly from the nebulizer solution at the end of
the experimental run time (after nebulization) showed no loss
of viable virus nor viral RNA, suggesting virus survival within the
nebulizer chamber (reservoir) is not affected by the mechani-
cal action of nebulization.
The difference between the RNA and pfu quantification is
remarkably similar between the different collection time-
periods, being of the order of 104e105 difference for each of
the 30min sampling periods, with the RNA loads being in the
range 107e109 and the corresponding pfu values being in the
range 102e104. There is a trend to this difference increasing at
the later sampling periods (90e120min) due to a more rapid
fall in pfu (i.e. virus viability) (Figure 2).
Discussion
These results suggest that detecting influenza RNA alone
may greatly overestimate the amount of viable virus available
to cause infection. For a healthy individual, the levels of viable
virus (w3000 virions) at 60e90min were still sufficient to cause
infection (assuming that 1 pfu corresponds to one virus/virus
genome, where 3 TCID50 is equivalent to 3000 viral genomes)
(Figure 2).6
Several processes may contribute to loss of virus viability:
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Figure 2. Quantification of viable virus (plaque-forming units,
pfu/m3) and viral RNA (copies/m3) recovered from air-sampling
after various suspension times, post-nebulization. Error bars
represent mean  1 standard deviation.chance of surface impaction damage, contact with toxic
airborne pollutants, desiccation or degradation), or the air-
sampling process. In addition, air-sampling can reduce virus
viability through creating sudden changes in the viral particles’
microenvironment, and/or induced shear stress.7 However, the
amount of viable virus loss in artificially produced aerosols,
such as those produced in this experiment, compared to
naturally produced aerosols from natural influenza-infected
volunteers remains unknown.
Two recent studies, using naturally influenza-infected hu-
man volunteers, found that whereas diagnostic swabs from the
respiratory tract showed relatively high influenza viral RNA
loads of up to 105e108 RNA copies/mL, there were much lower
levels (up to 103e104-fold less) of viable virus, recovered by
air-sampling, after exhaling or coughing.8,9 Although the sus-
pension times were much less for these human influenza ex-
periments (where infected patients coughed directly into
conical air-sampling receptors), the amount of viable virus loss
appears similar to that seen in this study. However, for human
volunteers, other additional mucosal/salivary immunological
factors may affect the amount of virus expelled in such exhaled
or coughed aerosols.10
These results indicate that influenza virus does not survive
well in the airborne state, at least under these experimental
conditions. Although detectable viral RNA remains relatively
stable, the numbers of viable virus appear to fall significantly,
with a 104e105 loss within 30e60min after aerosolization, with
further loss up to 120 min post nebulization. Further, larger
experiments may examine at what time-point the pfu count
drops to zero (undetectable). However, it is clear from the
experiments described here that when performing environ-
mental air-sampling for influenza (and possibly other envel-
oped RNA viruses), the detection of RNA by PCR, which
represents non-viable as well as viable virus, should be inter-
preted with caution unless combined with viral culture
methods.
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